Site head standing in a lab

Novartis Financial Results – Q2 2022

Novartis announced the company’s financial results for the second quarter and first half of 2022.

Ukraine response

June 01, 2022

Novartis resumes business in Ukraine

Learn More

More statements


Novartis Gene Therapies Global Managed Access Program

Novartis Gene Therapies recommits to Global Managed Access Program for 2021 so that children around the world can benefit from SMA treatment who otherwise would not have access to Zolgensma.

Read More